Abstract: Antiseptic agent delivery systems and methods are provided, one such system comprising: a reservoir configured to store an antiseptic solution, wherein the antiseptic solution comprises an aqueous solution of hypochlorous acid; an ultrasound generator coupled to the reservoir, wherein the ultrasound generator vaporizes the antiseptic solution into an antiseptic vapor; a nozzle to direct the antiseptic vapor to an affected area; and a housing coupled to the reservoir and the nozzle, wherein the housing comprises a panel to control the ultrasound generator.

Abstract: Systems and methods for treating drug resistant pneumonia and tuberculosis using hypochlorous acid (HOCl) are disclosed. Embodiments of the present disclosure relate to nebulizing HOCl as a method of treating drug resistant bacteria, in particular, bacterial pneumonia pathogens (i.e., Streptococcus pneumoniae) and Mycobacterium tuberculosis bacteria. The nebulized HOCl solution may be approximately 180 parts per million (PPM) of the aqueous solution and have a pH of less than 6.

Abstract: Systems and methods for disinfecting and deodorizing using low concentration hypochlorous acid solutions are disclosed. In one embodiment, a method may include delivering an disinfectant solution to PAP equipment, such as CPAP and BiPAP equipment, to disinfect the PAP equipment used by the patient, thereby preventing infection by the infectious diseases in the patient. The disinfectant solution may include an aqueous solution of hypochlorous acid. The hypochlorous acid may be between 30 parts per million (ppm) to 500 ppm of the aqueous solution.

Abstract: Systems and methods for prevention and treatment of infectious diseases using low concentration hypochlorous acid solutions are disclosed. In one embodiment, a method may include delivering an antiseptic solution to the medical equipment to disinfect the medical equipment used by the patient, thereby preventing infection by the infectious diseases in the patient. The antiseptic solution may include an aqueous solution of hypochlorous acid. The hypochlorous acid may be between 30 parts per million (ppm) to 500 ppm of the aqueous solution.

Abstract: A method of treating acute hypovolemia due to one or more medical conditions including sepsis with shock, hemorrhagic shock, burn injury, nephritic syndrome, and multiorgan failure by injecting an aqueous solution of hypochlorous acid to a patient in need thereof.

Abstract: A method of treating acute hypovolemia due to one or more medical conditions including sepsis with shock, hemorrhagic shock, burn injury, nephritic syndrome, and multiorgan failure by injecting an aqueous solution of hypochlorous acid to a patient in need thereof.

Abstract: A method of treating disease states associated with bacteria, a virus, a yeast, a mold, a fungus, a spore, a protozoa or a prion comprising a respiratory, oral, and internal delivery of hypochlorous acid (HOCl) via a nebulizer, an aerosolizer, an spray a spray bottle, an oral rinse, an oral gargle, a vaping device, and a diffuse.